The 23-valent pneumococcal polysaccharide vaccine market is booming, projected to reach over $6 billion by 2033, driven by aging populations and increased vaccination awareness. Learn about market trends, key players (Merck, Sinovac, Kangtai Bio), and future growth projections in this comprehensive analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
